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Cortical pencil lining on SWI MRI in NBIA
and healthy aging
Marlous C. M. van der Weijden1,2* , Peter Jan van Laar3,4, Roald A. Lambrechts1,5, Dineke S. Verbeek2† and
Marina A. J. Tijssen1†
Abstract
Background: Neurodegeneration with brain iron accumulation (NBIA) is characterized by pathological iron
accumulation in the subcortical nuclei and the cortex. As age-related iron accumulation studies in these structures
are lacking in healthy aging, we aimed to characterize the dynamics of age-dependent iron accumulation in
subcortical nuclei in healthy aging and selected NBIA cases. This is fundamental to understand the natural age-
related iron deposition in the healthy brain prior to using this marker as a potential prognostic or diagnostic tool in
neurodegenerative disorders.
Methods: Susceptibility-weighted imaging (SWI) scans from 81 healthy volunteers (0-79 years) and four genetically
confirmed patients suffering from NBIA (2-14 years) were obtained. We scored the presence or absence of pencil
lining of the motor cortex and putamen and analyzed the normalized SWI signal intensity ratio (NSIR) in five
subcortical nuclei.
Results: In healthy subjects, an age-dependent increase of pencil lining occurred starting from the second decade
of life and was present in all cases at the age of 50. In their first decade, NBIA patients showed no cortical pencil
lining, but we did observe putaminal pencil lining at this stage. In healthy subjects, age and NSIR of all nuclei
correlated positively and was particularly dynamic in early childhood until young adulthood in the globus pallidus,
dentate nucleus and red nucleus, but not in the caudate nucleus and putamen. NBIA patients showed an increased
NSIR in the globus pallidus only and not in the other subcortical nuclei compared to age-matched healthy subjects.
Conclusions: Cortical pencil lining is part of healthy aging. This should be considered when assessing this as a
potential marker in NBIA diagnosis and prognosis. Putaminal pencil lining has the potential to become a specific
marker for some subtypes of NBIA in the first decade of life, as it was only observed in NBIA and not in age-
matched healthy subjects. NSIR in the subcortical nuclei during healthy aging was shown to be dynamic,
accentuating the importance of having an age-dependent baseline.
Keywords: Iron accumulation, Susceptibility-weighted imaging, Cortical pencil lining, Healthy aging, NBIA
Background
Iron is an essential component for normal brain function
including energy production, mitochondrial respiration,
protein and DNA synthesis, as well as in the biosynthesis
of neurotransmitters and myelin [1–7]. Dysregulation
of iron homeostasis can cause neurotoxicity through
different mechanisms believed to be responsible for a
number of neurodegenerative disorders including neu-
rodegeneration with brain iron accumulation (NBIA)
[3, 8, 9]. NBIAs are a genetically and clinically hetero-
geneous group of movement disorders where iron
accumulation occurs in the brain, mostly in the basal
ganglia. Up to date, 10 different gene mutations caus-
ing NBIA have been identified, but a significant
portion of cases remain without a known genetic
cause [10, 11].
With current advances in brain imaging techniques,
the potential of using different imaging modalities as
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non-invasive markers for brain iron accumulating dis-
eases has increased, therefore becoming a corner stone
for corroborating clinical suspicion. For example, using
the T2/T2* MRI sequence, patients with mutations in
pantothenate kinase 2 (PANK2) show marked hyper-
intense signals in the globus pallidus with a hypoin-
tense surrounding, known as the “eye of the tiger”
sign [12, 13]. This feature is absent in other NBIA
subtypes, making its presence a specific sign for
PKAN. Additionally, a linear hypointense tracing of
the cortical motor area using susceptibility weighted
imaging (SWI), referred to as “cortical pencil lining”
is suggested to be a potential marker to discriminate
neuroferritinopathy patients from other NBIA sub-
types (PKAN or PLAN patients) [14].
To assess the discriminatory and/or prognostic poten-
tial of such radiologic signs, it is vital to understand the
natural age-related iron accumulation in healthy brains.
This is particularly relevant given that several post-
mortem and in vivo studies have demonstrated an age-
related increase in iron deposition in NBIA-linked brain
regions of previously healthy subjects [8, 14–18].
For the purposes stated above, we investigated the
presence or absence of cortical pencil lining on SWI in
81 healthy subjects ranging from birth to 79 years of age
and in 4 genetically confirmed NBIA subjects ranging
from 2 to 14 years as a small contrast group. The choice
for SWI stems from the present-day use of this sequence
in standard clinical care in many neurological evalua-
tions and its sensitivity for detecting iron. In addition, to
find potential sensitive discriminative targets for NBIA
and to further improve our knowledge of brain iron ac-
cumulation in healthy aging, we examined the presence
of putaminal lining and the dynamics of age-related SWI




Brain MRI scans of healthy subjects without known neu-
rodegenerative, psychiatric, cerebrovascular or post-
traumatic disease, were included from a research data-
base of the department of Radiology of the University
Medical Center Groningen (UMCG), Groningen, the
Netherlands. Subjects with the aforementioned diseases
were excluded. Written informed consent was obtained
from all subjects or their parents. The group included 40
men with a mean age of 39.6 years (range 5-79 years)
and 41 women with a mean age of 40 years (range 0-79
years). The demographic data of these 81 healthy sub-
jects is summarized in Table 1.
Four genetically diagnosed NBIA patients were also in-
cluded, three with a mutation in the WDR45 gene
(BPAN) and one case with a mutation in the PANK2
gene (PKAN) (see Additional file 1: Table S1 for further
details). The BPAN patients were diagnosed at 6, 7 and
14 years of age and the PKAN patient at 2 years of age.
The corresponding SWI scans were made at the time of
diagnosis.
MRI acquisition
Imaging was performed using a 1.5-Tesla whole body
system (Magnetom Aera, Siemens, Erlangen, Germany).
The SWI sequence was a 3D velocity compensated gra-
dient echo sequence. Magnitude and Phase images were
obtained in the axial plane. The Phase images were high
pass filtered to remove unwanted artefacts. The magni-
tude image was combined with the Phase image to cre-
ate an enhanced contrast magnitude susceptibility
image. The parameters of the SWI sequence were Repe-
tition Time (TR): 49 ms, Echo Time (TE): 40 ms, Flip
angle: 15°, Field of View read: 230 mm, slices per slab:
80, slice thickness: 1.6 mm, voxel size: 0.7 × 0.7 × 1.6 mm,
phase encoding direction: R> > L and transversal orienta-
tion, bandwidth: 80 Hz/Px with flow compensation, aver-
ages: 1, and total scan time: 6:15 min.
Image analysis
All SWI scans were blindly analyzed by a senior neuro-
radiologist (PL). The SWI sequence can show a fine
band of low signal following the contour of the motor
strip of the cerebral cortex and in the periphery of the
putamen. This appears as a thin line of low signal look-
ing as if traced with a black pencil [14]. This pencil lin-
ing in the motor strip of the cerebral cortex was scored
with a system based on previous methods described in
the literature as present or absent [14].
To assess SWI signal intensity in the caudate nucleus,
putamen, globus pallidus, red nucleus and dentate nu-
cleus, we used a region-of-interest (ROI) method similar
to Meijer et al. (2015), with the exception of using a
grading system for the signal intensity values.[19] In
Table 1 Demographic data of healthy study subjects per
decade at moment of scanning
Decade N M/F Mean age in
years (range)
1 10 5/5 4.4 (0-9)
2 9 3/6 15.1 (10-19)
3 10 6/4 25.1 (22-29)
4 12 8/4 34.5 (30-37)
5 10 5/5 43.7 (41-49)
6 10 5/5 56.3 (51-59)
7 11 4/7 65.0 (61-69)
8 9 4/5 73.9 (70-79)
Total 81 40/41 (0-79)
N number of subjects, M male, F female
Weijden et al. BMC Neurology          (2019) 19:233 Page 2 of 8
short, the ROI method was used to evaluate the SWI se-
quences on a PACS workstation (Carestream). A 5mm2
circular ROI was placed bilaterally in the caudate nucleus,
putamen, globus pallidus, red nucleus and dentate nucleus
on a single slice. Given that no significant differences in
intensities between the normalized SWI scan values of the
ROIs of both hemispheres were observed (paired-samples
t-tests p ≥ 0.8), the obtained intensities for the nuclei of
both hemispheres were averaged. The signal intensity of
the CSF was measured by ROI placement in the lateral
ventricle. To limit the potential non-uniformity of the
CSF signal, the signal intensity of two measurements bilat-
erally in the lateral ventricle were averaged. Additionally,
the ROIs were placed avoiding vessels, flow voids, the
choroid plexus and were not including the edges of the
structures. The ROI method was performed by a senior
neuroradiologist (PL) blinded to the clinical symptoms
and diagnosis. See Additional file 1: Figure S1 for an ex-
ample placement of an ROI bilateral in the lateral ven-
tricle and the left caudate nucleus.
To correct for inconsistencies in the reference standard,
we calculated the ratio of the SWI signal intensity in the
cerebrospinal fluid (CSF) of the lateral ventricle (LV) to
the signal intensity of the different nuclei (normalized sig-
nal intensity ratio (NSIR) = SWI signal intensity of the LV
/ SWI signal intensity of the subcortical nucleus).
Statistical analysis
All statistical analyses were performed with SPSS
(version 23, IBM, USA). Prior to analyzing the effect
of age on brain iron deposition, potential confounding
factors were tested by assessing possible imbalances
within and between decades of life. In addition, distri-
butions and assumptions within the group of healthy
subjects were checked and because of the non-
normality of the data, non-parametric testing was
used to compare for group differences and gender
effects (Mann-Whitney U test). Given that the healthy
subjects showed an equal distribution of gender, mean
age, and number of subjects between and within each
decade of life, we did not include these factors in the
study analyses. Analysis of Variance (ANOVA) was
performed to evaluate potential group differences. To
correct for multiple comparisons between the five
ROIs, a Bonferroni corrected p-value ≤0.01 (0.05/5)
was considered significant for omnibus F-tests. To
evaluate the correlation between age and brain iron
content, a Spearman’s rank correlation coefficient was
calculated for the different ROIs. Figures were made
in R (version 3.0.0, R Foundation for Statistical
Computing, Vienna, Austria). Since no equal distributions
between NBIA patients and healthy subjects was present
due to the small number of patients, no statistical analysis
was performed between the two groups.
Results
Cortical pencil lining
The qualitative SWI scan analysis revealed that the pres-
ence of cortical pencil lining was positively correlated
with age. More specifically, up to 50% of the healthy
subjects in their third decade of life showed cortical pen-
cil lining as well as all subjects older than 50 years of age
(Fig. 1 and Additional file 1: Figure S2). In Additional
file 1: Figure S2 differences in the presence or absence of
cortical pencil lining in healthy subjects age 35 are
shown. No cortical pencil lining was observed in healthy
subjects in their first decade of life.
Notably, no cortical pencil lining was observed in four
NBIA patients (range 2-14 years), suggesting that cortical
pencil lining is not temporally linked to the pathological
iron accumulation seen in the globus pallidus of these
young PKAN and BPAN cases.
Putaminal pencil lining
The presence of putaminal pencil lining was also posi-
tively correlated with age. All subjects older than 20
years of age exhibited putaminal pencil lining (Fig. 1).
No putaminal pencil lining was observed in healthy sub-
jects in their first decade of life. Putaminal pencil lining
was observed in two BPAN cases who were diagnosed in
their first decade of life, but was absent in the 2-year-old
PKAN and 14-year-old BPAN patients (Fig. 2).
Subcortical normalized signal intensity ratio (NSIR)
To further study the natural dynamics of iron accumula-
tion in the brain during healthy aging, we investigated
the normalized signal intensity ratio (NSIR) of SWI
scans of the caudate nucleus, putamen, globus pallidus,
red nucleus and dentate nucleus in our cohort of healthy
subjects over different decades. We observed significant
positive correlations between age and the NSIR of all
subcortical nuclei (Fig. 3). The strongest correlations
were detected for the red nucleus and putamen (both R2
of 0.67, p < 0.001; Fig. 3b and e), whereas weaker but still
significant correlations were observed for the caudate
nucleus, globus pallidus, and dentate nucleus (R2 of 0.44,
0.35, and 0.47, respectively; all p < 0.001). The globus
pallidus showed a marked significantly increased NSIR
during the first decade of life (p < 0.01) followed by a
plateau phase starting around 20 years of age (Fig. 3a
and Table 2). This suggests that iron accumulation oc-
curs relatively fast early in life in the globus pallidus.
The NSIR of the red nucleus and dentate nucleus signifi-
cantly increased up to 40 years of age (p < 0.01), and was
then followed by a plateau phase, suggesting that iron
accumulated more gradually over time in these sub-
cortical nuclei. Additionally, the caudate nucleus and
putamen showed a more linear increase of NSIR,
reflecting a quite modest iron accumulation over time
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Fig. 1 Age-related iron deposition lining the motor cortex and putamen in 81 healthy subjects. The graph shows the percentage of healthy
subjects (Y-axis) per decade of life (X-axis) that exhibit hypointense signals on SWI in (a) the motor cortex and (b) the putamen
Fig. 2 Presence or absence of putaminal pencil lining. Representative SWI images of NBIA patients (WDR45 and PANK2 mutation carriers) and
age-matched healthy subjects (2, 6, 7 and 14 years old) showing the absence or presence of putaminal pencil lining
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(Fig. 3 and Table 2). The increase in NSIR was only sig-
nificantly different between the first and eighth decade of
life in the putamen (p < 0.01), whereas significantly in-
creased NSIR were observed between the first three and
the eighth decade of life in the caudate nucleus (p < 0.01).
The four NBIA patients showed an increased NSIR in
the globus pallidus compared to age-matched healthy
subjects that was not observed for the other subcortical
nuclei. In addition, the dynamics of the NSIR in the
other subcortical nuclei of the NBIA cases showed a
Fig. 3 Age-related regional SWI signal intensity. Normalized signal intensity ratio (NSIR) (ratio between the signal intensity of the lateral ventricle
and a region of interest (ROI); right and left hemisphere values are averaged) and the signal intensity of the ROI in five subcortical nuclei: globus
pallidus (a), red nucleus (b), dentate nucleus (c), caudate nucleus (d), and putamen (e) over time. Red rounds, blue triangles and green squares
denote healthy females, healthy males and NBIA subjects, respectively. The thick continuous line is the smoothened conditional mean of healthy
subjects. The shade around the line represents the simultaneous prediction bounds of the 95% confidence intervals for the mean. X-axis: age in
years; Y-axis: NSIR
Table 2 Quantitative age-related iron accumulation indicated by NSIR signal intensities per nucleus
Shaded boxes: significant Bonferroni corrected differences (p < 0.01). Numbers denoted in superscript x = significant difference compared to decade x. Data is
shown as mean ± SD
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similar pattern as seen in healthy subjects (Fig. 3). Al-
though no statistical analysis could be performed due to
the small number of NBIA cases, our SWI scan data
points to pathological iron accumulation in the globus
pallidus as a hallmark of NBIA.
Discussion
This study, where iron imaging data from the very early
decades of life are reported, showed that cortical pencil
lining is potentially less specific as a general marker for
NBIA. Instead, this sign also appears to be a part of
healthy aging as it is encountered in the majority of
healthy individuals older than 30 years of age. On the
other hand, putaminal pencil lining in the first decade of
life was seen in specific NBIA cases only and not in age-
matched healthy individuals suggesting its potential as a
specific marker of pathological iron accumulation in spe-
cific subtypes of young NBIA patients. Finally, this work
characterized NSIR in subcortical nuclei of the brain
during healthy aging, where a positive correlation be-
tween age and NSIR in all subcortical nuclei was shown.
None of our NBIA patients, including BPAN and
PKAN, showed cortical pencil lining in their first or
second decade of life. The presence of cortical pencil
lining was seen in three neuroferritinopathy cases (37,
54 and 79 years of age) as reported in the work of
Batla et al. [14]. Although we were not able to include
neuroferritinopathy cases in our study, the findings in
our study suggest that the presence of cortical pencil
lining in these neuroferritinopathy cases might at least
partly be due to age, as 80% of the healthy cases in our
cohort showed cortical pencil lining between 30 and
40 years and more than 50% between 20 and 30 years
of age. Additionally, this might also be explained by a
more diffuse iron accumulation throughout the brain
in neuroferritinopathy cases, whereas the iron accu-
mulation in BPAN and PKAN cases is more isolated
to the basal ganglia.
The presence or absence of cortical pencil lining in pa-
tients older than 20 years of age can therefore not be
used as a specific marker. Alternatively, we speculate
that quantification of the different pencil linings may
discriminate between NBIA subtypes and between NBIA
patients and healthy subjects. Such quantification has
been demonstrated to be useful in the diagnosis of
amyotrophic lateral sclerosis (ALS) and primary lateral
sclerosis (PLS) [20, 21]. It should be noted that current
approaches for diagnosing NBIA subtypes are based on
a combination of clinical characteristics, genetic testing
and MRI findings. Nevertheless, in 30% of the cases no
genetic confirmation is found and the diagnosis can only
be made on MRI findings coupled with clinical suspicion
[22]. Furthermore, because of the broad range of pos-
sible clinical features present in NBIA, MRI findings
often provide the first strong clue for the diagnosis. This
further accentuates the importance of this kind of re-
search providing a normal baseline for a frequently used
MRI sequence.
To our knowledge, this is the largest study on iron de-
position in the brain using SWI focusing on healthy sub-
jects that also includes individuals in their first decade of
life. This period of life is of particular interest given the
age of onset of the classic disease types of NBIA. This is
further substantiated by the identification of putaminal
pencil lining exclusively in young NBIA cases but not in
age-matched healthy individuals. This suggests that the
occurrence of putaminal pencil lining in the first decade
of life may be a potential marker in specific subtypes of
NBIA, as none of the healthy subjects in their first dec-
ade of life had any signs of putaminal pencil lining.
In the early period of life we observed dynamic iron
accumulation in the globus pallidus, red nucleus, and
dentate nucleus. The non-linear pattern of SWI signal
intensity change reflecting iron accumulation in the
globus pallidus was reported before [18]. However,
the exponential increase of iron accumulation in the
red nucleus and dentate nucleus has, to our know-
ledge, not been described before. In contrast, the
caudate nucleus and putamen showed a more gradual
increase which is in line with previously published
work using T2* and quantitative susceptibility map-
ping MRI [23–27]. It appears that early onset neuro-
degenerative disorders associated with aberrant iron
homeostasis such as subtypes of NBIA and Frie-
dreich’s ataxia preferentially show increased iron ac-
cumulation in nuclei where there is exponential
increase in iron content early on in life, such as the
globus pallidus and dentate nucleus [28, 29]. When
compared to acquired, late onset, neurodegenerative
disorders such as Parkinson’s disease, multiple system
atrophy and Alzheimer’s disease we mostly find pref-
erential iron accumulation in different nuclei, such as
the caudate nucleus and putamen [19, 30, 31]. Specu-
latively, this may point to a primary versus secondary
effect of pathological brain iron accumulation, i.e. ac-
celerated accumulation leading to pathology in NBIA
cases and secondary excess iron accumulation due to
neurodegeneration leading to further damage in ac-
quired neurodegenerative disorders.
Some limitations should be noted in this study. First,
the sample size of subjects per decade is relatively small
and only a few cases of NBIA are examined as a contrast
group. Future studies including higher subjects are ad-
visable to confirm the validity and normal ranges of
these results. Second, although SWI was used, which is a
well-established surrogate marker for in vivo iron quan-
tity [32], the signal intensity may be affected by other
components such as calcium and lipids. However, the
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use of a standardized scan sequence widely used in the
clinic, as well as using the same MRI scanner are
strengths of this study making direct comparisons be-
tween subjects possible. The results presented here are
derived from a 1.5-Tesla field strength scanner and can
be used as a reference for this field strength. Neverthe-
less, it is important to validate these results on higher
scanner field strengths with higher signal-to-noise ratios
such as 3-Tesla before articulating definitive recommen-
dations on using this method as a biomarker.
Conclusions
In this study, we showed that cortical pencil lining may
not be a biomarker for NBIA in general. In contrast, pu-
taminal pencil lining could potentially be a useful
marker to discriminate between specific subtypes of
young NBIA patients and healthy subjects. The “natural”
level of age-related iron content in the globus pallidus
should be taken into consideration when interpreting
SWI scans of NBIA cases or individuals with other neu-
rodegenerative disorders with iron accumulation. Finally,
we provide a normal baseline for brain iron accumula-
tion using NSIR during eight decades of healthy aging
and suggest to further explore iron levels of the red and
dentate nuclei to gain further insights in the significance
of their dynamic iron accumulation.
Additional file
Additional file 1: Table S1. NBIA patient demographics. Figure S1.
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Presence or absence of cortical pencil lining.
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